- Previous Close
0.0800 - Open
0.0766 - Bid 0.0700 x --
- Ask 0.0900 x --
- Day's Range
0.0700 - 0.0900 - 52 Week Range
0.0300 - 0.8000 - Volume
811,710 - Avg. Volume
5,836,735 - Market Cap (intraday)
481,799 - Beta (5Y Monthly) -1.51
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Cel AI PLC, together with its subsidiaries, engages in the manufacture and sale of biosynthetic cannabinoids-based consumer products in the United Kingdom. The company provides cannabinoid solutions for skincare and ingestible products. It offers its products through retailers; direct to consumers through its website; and online. The company was formerly known as Cellular Goods PLC and changed its name to Cel AI PLC in February 2024. Cel AI PLC was incorporated in 2018 and is based in London, United Kingdom.
www.getcel.ai5
Full Time Employees
August 31
Fiscal Year Ends
Sector
Industry
Recent News: CLAI.L
View MorePerformance Overview: CLAI.L
Trailing total returns as of 1/7/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CLAI.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CLAI.L
View MoreValuation Measures
Market Cap
481.80k
Enterprise Value
268.17k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
26.85
Price/Book (mrq)
0.94
Enterprise Value/Revenue
14.95
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-50.24%
Return on Equity (ttm)
-86.60%
Revenue (ttm)
54.16k
Net Income Avi to Common (ttm)
-2.11M
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
1M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-1.73M